Author Archives: e.thomassen@hdmt.technology

Summit grant NWO

The Summit Grant offers research funding for ten years to scientific consortia that have proved in the course of their existing collaboration that they are among the absolute world leaders, or are very close to reaching that status and can make the leap to the very top with the help of this instrument. Consortia can be nominated by the boards of knowledge institutions. Purpose The Summit Grant is intended for scientific consortia that have proved in the course of their existing collaboration that they are among the absolute world leaders, or are very close to reaching that status and can...

Read more

Horizon Europe: Destination 5. Unlocking the full potential of new tools, technologies & digital solutions for a healthy society. HORIZON-HLTH-2024-TOOL-05-06-twostage (RIA)

Innovative non-animal human-based tools and strategies for biomedical research Develop and/or use tools and strategies that address critical areas of biomedical research where animal-models are currently used but are of limited translational value for investigation and development of prevention and treatment. Such advanced tools and strategies should aim at a better understanding of the pathogenesis of disorders that feature a high impact on public health and exhibit a high rate of animal use or severe animal suffering and enable to develop biomedical concepts with increased translational value, thereby ultimately leading to improved disease prediction, prevention and treatment. The innovative tools...

Read more

Horizon Europe: Destination 5. Unlocking the full potential of new tools, technologies & digital solutions for a healthy society. HORIZON-HLTH-2023-TOOL-05-03 (RIA)

Integrated, multi-scale computational models of patient patho-physiology (‘virtual twins’) for personalised disease management Develop multi-scale and multi-organ, dynamic, interoperable, modular computational models, capable of accurately simulating the individual patient pathophysiology, spanning different anatomical scales, from the molecular to cell, tissue, organ and systems level, as necessary. Proposals should be multidisciplinary and focus on groups of communicable and/or non-communicable diseases. Goal: improved personalized diagnostics, medicinal devices, and therapeutic strategies tailored to the individual patient pathophysiology. Call: HORIZON-HLTH-2023-TOOL-05-03 (RIA) Total budget: 50 M€ Per project: 8-10 M € Open: 12 January 2023 Deadline: 13 April 2023 More information: Pre-publication work programs Horizon...

Read more

Horizon Europe: Destination 3. Tackling diseases and reducing disease burden. HORIZON-HLTH-2024-DISEASE-03-14- two-stage

Tackling under-researched high-burden medical conditions Call: HORIZON-HLTH-2024-DISEASE-03-14- two-stage Total budget: 25 M€ Per project: 6-7 M € Open: 23 March 2023; Deadline: stage 1, 19 September 2023; stage 2, 11 April 2024 More information: Pre-publication work programs Horizon Europe: Horizon Europe work programmes (europa.eu) see cluster 1 work program

Read more

Horizon Europe: Destination 3. Tackling diseases and reducing disease burden. HORIZON-HLTH-2024-DISEASE-03-13- two-stage

Validation of fluid-derived biomarkers for the prediction and prevention of brain disorders Call: HORIZON-HLTH-2024-DISEASE-03-13- two-stage Total budget: 25 M€ Per project: 6-8 M € Open: 23 March 2023; Deadline: stage 1, 19 September 2023; stage 2, 11 April 2024 More information: Pre-publication work programs Horizon Europe: Horizon Europe work programmes (europa.eu) see cluster 1 work program

Read more

Free Webinar On Demand: Improve Rigor and Reproducibility in Stem Cell Research

Learn About the ISSCR’s Recommendations to Improve Rigor and Reproducibility in Stem Cell Research via the On-Demand Webinar. View the Free, On-Demand Webinar to review the updated draft of the ISSCR’s quality standards and core principles for the laboratory culture and characterization of both adult and pluripotent human stem cells and in vitro model systems using them. These practical standards can set researchers up for success, enhance rigor in preclinical research, and ultimately strengthen the pipeline of therapies for patients. Source: ISSCR

Read more

WC12 Abstract deadline extended

The 12th World Congress on Alternatives and Animal Use in the Life Sciences will take place between August 27-31 2023, at Niagara Falls, Canada. Due to high demand—and in appreciation of all your efforts—the abstract deadline has been extended! Abstract submission deadline is Monday, February 20, 2023, 12:00 pm Canada/USA EST. For more information and submission of the abstract see the conference website.

Read more

MPS World Summit 2023 abstract submission extended

The 2nd MPS world summit 2023 in Berlin is less than 6 months away. The organizers are happy to announce that deadline for abstract submission is extended! Submit your abstract by February 15th 2023! Early bird registration is open until March 31st. EUROoCS members get a discount during the early bird registration.   Programme: Check the program, keynote speakers, venue and social events: https://mpsworldsummit.com Abstract submission: https://mpsworldsummit.com/2023-abstract-submission/ Registration: here Hotel: There is a limited number of rooms at the conference hotel reserved. Book here.  

Read more

hDMT Consortium Meeting Registration and Abstract submission

All hDMT members are invited to attend the 6th annual hDMT Consortium Meeting, on Friday 25th of November 2022 at the Eenhoorn Meeting Center Amersfoort – STUDIO33 (opposite to the main entrance of Amersfoort CS). The hDMT consortium meeting is a closed meeting, exclusively for all researchers who are actively involved in hDMT research, from student to professor, with the aim of getting to know each other and to learn what is going on in hDMT – with a few keynote lectures, a lot of floor time for our junior researchers and ample time for networking. For registration and abstract...

Read more

The EPAA European Partnership for Alternatives (EPAA3Rs) 2022 3Rs Science Prize is open for submissions.

The 3Rs science prize is granted every two years to a scientist with an outstanding contribution to 3Rs. We want to promote positive contributions from industry or academia and encourage more scientists to focus their research on the 3Rs goals. Scientists working on relevant methods for regulatory testing (e.g. safety, efficacy, batch testing) providing an outstanding contribution to the use of the 3Rs may apply for the prize. The EPAA European Partnership for Alternatives (EPAA3Rs) 2022 3Rs Science Prize is open for submissions. For more information and how to apply see here. Source: https://single-market-economy.ec.europa.eu/calls-expression-interest/3rs-science-prize-2022-call-submissions_en

Read more